Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tarsus Pharmaceuticals (TARS) Amortizatization of Intangibles (2020 - 2025)

Historic Amortizatization of Intangibles for Tarsus Pharmaceuticals (TARS) over the last 6 years, with Q3 2025 value amounting to $200000.0.

  • Tarsus Pharmaceuticals' Amortizatization of Intangibles rose 10000.0% to $200000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 41951.22%. This contributed to the annual value of $4.2 million for FY2024, which is 3319.63% up from last year.
  • Per Tarsus Pharmaceuticals' latest filing, its Amortizatization of Intangibles stood at $200000.0 for Q3 2025, which was up 10000.0% from $200000.0 recorded in Q2 2025.
  • Tarsus Pharmaceuticals' 5-year Amortizatization of Intangibles high stood at $1.5 million for Q1 2023, and its period low was -$87000.0 during Q3 2021.
  • In the last 5 years, Tarsus Pharmaceuticals' Amortizatization of Intangibles had a median value of $200000.0 in 2025 and averaged $460266.7.
  • In the last 5 years, Tarsus Pharmaceuticals' Amortizatization of Intangibles crashed by 25535.71% in 2021 and then surged by 108480.0% in 2024.
  • Quarter analysis of 5 years shows Tarsus Pharmaceuticals' Amortizatization of Intangibles stood at $294000.0 in 2021, then soared by 326.19% to $1.3 million in 2022, then crashed by 90.02% to $125000.0 in 2023, then soared by 1084.8% to $1.5 million in 2024, then plummeted by 86.5% to $200000.0 in 2025.
  • Its Amortizatization of Intangibles stands at $200000.0 for Q3 2025, versus $200000.0 for Q2 2025 and $1.3 million for Q1 2025.